Aims & Scope
JBBS publishes rigorously peer-reviewed, open-access research that advances biotechnology and biomedical science from molecular insights to clinical translation.
Mission & Editorial Philosophy
The Journal of Biotechnology and Biomedical Science (JBBS) exists to accelerate trustworthy discoveries that transform health, industry, and society. We curate multidisciplinary research spanning fundamental biology, engineering breakthroughs, computational innovation, and patient-centred applications. Every article we publish must deliver scientific rigor, ethical transparency, and translational relevance for a global readership that includes laboratory scientists, clinicians, data scientists, regulatory teams, and policy makers.
Advance Scientific Excellence
Publish research that expands foundational understanding of biological systems, unlocks new therapeutic strategies, and elevates methodological standards across biotechnology and biomedical science.
Bridge Bench to Bedside
Champion studies that demonstrate translational pathways—from advanced diagnostics, device engineering, and biomaterials to clinical trials, real-world implementations, and population health impact.
Enable Responsible Innovation
Highlight ethical, regulatory, and societal implications of biotechnology while promoting responsible data stewardship, equitable access, and sustainable biomanufacturing practices.
JBBS welcomes original research, reviews, methods, perspectives, short communications, data descriptors, clinical case reports, and implementation studies that align with the themes below. We prioritise submissions that integrate multiple disciplines, apply robust analytics, and offer actionable insights.
Genomics & Transcriptomics
- Genome engineering (CRISPR, base/prime editing, synthetic chromosomes)
- Single-cell omics, spatial transcriptomics, and lineage tracing
- Gene regulation networks, epigenetics, and RNA therapeutics
Proteomics & Metabolomics
- Quantitative proteomics, post-translational modifications, interactome mapping
- Metabolic engineering, systems metabolism, synthetic pathways
- Biomarker discovery for diagnostics and personalised therapy
Cellular Engineering
- Stem cell biology, regenerative medicine, and organoid systems
- Cellular immunotherapies (CAR-T/NK, TCR engineering)
- Cellular reprogramming, differentiation, and microenvironment modulation
Smart Biomaterials
- Nanomaterials, responsive hydrogels, self-assembling scaffolds
- Bioprinting, tissue scaffolding, and bioinspired materials
- Drug delivery platforms including nanoparticles, exosomes, and microdevices
Biomedical Devices & Diagnostics
- Lab-on-chip systems, portable diagnostics, biosensors
- Wearables for personalised health monitoring
- Imaging technologies, photonics, and point-of-care solutions
Biomechanics & Bioelectronics
- Bioelectronic medicine, neural interfacing, prosthetics
- Mechanobiology and biomechanics of tissues and implants
- Robotics and automation in biomedical contexts
We seek submissions that leverage computational power to decode complex biological systems and inform clinical decision-making.
- Artificial intelligence, machine learning, and deep learning in biotechnology
- Systems biology, network modelling, and multi-omics integration
- Digital twins, virtual clinical trials, and simulation-based design
- Bioinformatics pipelines, algorithm benchmarking, and reproducibility frameworks
- Data governance, FAIR data practices, and privacy-preserving analytics
Drug Discovery & Design
- Target identification, structure-guided design, fragment-based screening
- Protein and peptide therapeutics, small molecules, nucleic acid drugs
- AI-assisted and high-throughput discovery platforms
Pharmacogenomics & Precision Medicine
- Biomarker-driven therapy selection, companion diagnostics
- Population genetics, pharmacogenomic diversity, and health equity
- Adaptive clinical trial design and real-world evidence studies
Bioprocessing & Biomanufacturing
- Cell culture optimisation, bioreactor design, scale-up strategies
- Continuous manufacturing, quality-by-design, GMP compliance
- Sustainable production, supply chain resilience, circular bioeconomy
- Clinical trials and observational studies translating biotech innovations to patient care
- Public health biotechnology: surveillance, vaccine platforms, outbreak response
- Microbiome, nutrigenomics, precision nutrition, and lifestyle medicine
- Digital therapeutics, telehealth integration, and health informatics
- Regenerative and restorative medicine impact evaluations
JBBS encourages submissions that reflect diverse geographic perspectives, address regional health priorities, and foster cross-sector collaboration among academia, industry, government, and non-profits. We welcome:
- Comparative studies evaluating biotechnology adoption across healthcare systems
- Regulatory science analyses that inform policy harmonisation and ethical governance
- Cross-sector partnerships for technology transfer, capacity building, and training
Responsible biotechnology advances human welfare. JBBS actively seeks work that:
- Addresses ethical considerations, biosafety, dual-use risk, and governance frameworks
- Explores equitable access, affordability, and inclusive design for biotechnology solutions
- Develops sustainable bioprocesses, circular bioeconomy strategies, and low-carbon innovation
Original Research
Full-length studies presenting novel data, mechanistic insights, or translational outcomes. Must demonstrate rigorous methodology and statistical integrity.
Reviews & Meta-Analyses
State-of-the-art syntheses, systematic reviews, scoping reviews, and quantitative meta-analyses that map emerging landscapes or reconcile conflicting evidence.
Methods & Protocols
Innovative experimental techniques, computational pipelines, and validated protocols made available for community adoption.
Short Communications
Brief reports of significant findings, preliminary data, or proof-of-concept technologies that warrant rapid dissemination.
Clinical Case Reports & Series
Well-documented real-world implementations of biotechnology, highlighting patient outcomes, safety considerations, or practice-changing insights.
Perspectives & Policy Analyses
Expert commentaries, regulatory roadmaps, and future outlook pieces that stimulate debate and strategic planning.
JBBS supports open science and reproducibility. We encourage or require:
- Deposition of omics datasets in public repositories (GEO, SRA, ArrayExpress) with accession numbers cited.
- Sharing of code and models via GitHub, Zenodo, or similar platforms.
- Use of reporting guidelines (MIAME, PRISMA, STARD, CONSORT) and submission of completed checklists as supplementary material.
Data Availability: Manuscripts must include a dedicated data availability statement detailing how readers can access underlying datasets, materials, and protocols.
- Convergence of AI, robotics, and wet-lab automation for next-generation discovery
- Climate-resilient biotechnology for agriculture, environmental remediation, and sustainable materials
- Biosecurity innovations, pathogen detection, and surveillance platforms
- Regenerative interfaces—combining bioelectronics, cell therapies, and smart implants
- Responsible human enhancement, neurotechnology, and ethical boundaries in biotechnology
We welcome contributions from:
- Academic researchers pushing the boundaries of molecular biology, engineering, computational science, or clinical practice.
- Clinician scientists translating novel diagnostics, therapeutics, and devices to patient care.
- Industry innovators developing scalable biotech solutions and sharing validated evidence.
- Public health leaders, policy makers, and non-profit organisations piloting biotechnology programs in real-world settings.
Collaborate with us to amplify your research, shape special issues, or co-develop thematic series. We value partnerships with professional societies, research consortia, innovation hubs, and training programmes seeking to disseminate high-quality work.
Share Your Breakthrough with JBBS
Submit your manuscript, propose a special issue, or register as a reviewer to join a multidisciplinary community committed to excellence in biotechnology and biomedical science.
Before submitting, confirm your manuscript aligns with JBBS expectations:
- Articulates how findings advance biotechnology or biomedical science beyond existing literature.
- Demonstrates methodological transparency, including statistical details, controls, and validation cohorts.
- Addresses translational relevance—whether through patient benefit, industrial scalability, or policy influence.
- Includes ethics approvals, data availability statements, and conflict disclosures.
- Provides accessible visuals, summary graphics, or infographics suited to an interdisciplinary audience.
Last updated: September 2025. JBBS reviews its aims and scope annually to reflect scientific advances, community needs, and ethical imperatives.
